High-dose UVA1 therapy for atopic dermatitis: Results of a multicenter trial
Authors:
- Thomas L. DiepgenTDThomas L. Diepgen
- Thomas A. LugerTLThomas A. Luger
- Stephan GrabbeSGStephan Grabbe
- Hans MeffertHMHans Meffert
- Niels SönnichsenNSNiels Sönnichsen
- Wolfgang CzechWCWolfgang Czech
- Alexander KappAKAlexander Kapp
- Helger StegeHSHelger Stege
- Markus GreweMGMarkus Grewe
- Erwin SchöpfESErwin Schöpf
- 1 April 1998
- journal article
- clinical trial
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 38 (4) , 589-593
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- High-Dose Ultraviolet A1 (UVA1), but Not UVA/UVB Therapy, Decreases IgE-Binding Cells in Lesional Skin of Patients with Atopic EczemaJournal of Investigative Dermatology, 1996
- Immunoglobulin E-Binding Structures on Antigen-Presenting Cells Present in Skin and BloodJournal of Investigative Dermatology, 1995
- Interleukin-10 Production by Cultured Human Keratinocytes: Regulation by Ultraviolet B and Ultraviolet A1 RadiationJournal of Investigative Dermatology, 1995
- FcϵRI on human Langerhans cells: a receptor in search of new functionsImmunology Today, 1994
- Lesional expression of interferon-γ in atopic eczemaThe Lancet, 1994
- Recombinant interferon gamma therapy for atopic dermatitisJournal of the American Academy of Dermatology, 1993
- Serum eosinophil cationic protein (ECP) is a sensitive measure for disease activity in atopic dermatitisBritish Journal of Dermatology, 1992
- High-dose UVA1 therapy in the treatment of patients with atopic dermatitisJournal of the American Academy of Dermatology, 1992
- Eosinophil cationic protein in sera of patients with atopic dermatitisJournal of the American Academy of Dermatology, 1991
- Combined UVA-UVB versus UVB phototherapy for atopic dermatitis: A paired-comparison studyJournal of the American Academy of Dermatology, 1990